Juno Capital takes 1.5% stake in Domainex, drug discovery services firm
Published
Juno Capital entered Domainex’s register with 9,883 D preference shares, giving the fund a 1.5% stake. The wider register also records D preference share additions for Bury Fitzwilliam-Lay & Partners LLP and MNL Nominees Limited, amounting to 7.4% and 4.0% of the company respectively. The statement was filed on 25 August 2026 for changes between 15 January and 23 June 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| Exited | UCL BUSINESS PLC | 165,175 | — | A ORDINARY SHARES 136,835 C PREFERENCE SHARES 14,312 B ORDINARY SHARES 14,028 |
| Exited | BURY FITZWILLIAM-LAY & PARTNERS | 7,156 | — | C PREFERENCE SHARES 7,156 |
| Exited | UNIVERSITY COLLEGE LONDON | 0 | — | A ORDINARY SHARES 0 |
| New shareholder | UCL VENTURES LIMITED | 165,175 | — | A ORDINARY SHARES 136,835 C PREFERENCE SHARES 14,312 B ORDINARY SHARES 14,028 |
| New shareholder | JUNO CAPITAL | 9,883 | — | D PREFERENCE SHARES 9,883 |
| Increased | BURY FITZWILLIAM-LAY & PARTNERS LLP | 120,894 | +85% | B ORDINARY SHARES 50,858 D PREFERENCE SHARES 48,440 A ORDINARY SHARES 14,440 C PREFERENCE SHARES 7,156 |
Current shareholders (14)
| Shareholder | Total shares | Share classes |
|---|---|---|
| MNL NOMINEES LIMITED | 167,893 | A ORDINARY SHARES 31,829 B ORDINARY SHARES 105,304 C PREFERENCE SHARES 4,711 D PREFERENCE SHARES 26,049 |
| UCL VENTURES LIMITED | 165,175 | A ORDINARY SHARES 136,835 B ORDINARY SHARES 14,028 C PREFERENCE SHARES 14,312 |
| BURY FITZWILLIAM-LAY & PARTNERS LLP | 120,894 | A ORDINARY SHARES 14,440 B ORDINARY SHARES 50,858 C PREFERENCE SHARES 7,156 D PREFERENCE SHARES 48,440 |
| CITY PARTNERSHIP NOMINEE LIMITED | 17,137 | A ORDINARY SHARES 2,219 B ORDINARY SHARES 14,918 |
| TAKEDA VENTURES INC | 12,000 | A ORDINARY SHARES 12,000 |
| BIRKBECK COLLEGE | 11,904 | A ORDINARY SHARES 11,904 |
| INSTITUTE OF CANCER RESEARCH | 11,904 | A ORDINARY SHARES 11,904 |
| JUNO CAPITAL | 9,883 | D PREFERENCE SHARES 9,883 |
| LUNA NOMINEES LTD | 3,266 | B ORDINARY SHARES 3,266 |
| G THOMSON HOLDINGS LTD | 3,178 | B ORDINARY SHARES 3,178 |
| 2012 LLP | 1,490 | B ORDINARY SHARES 1,490 |
| ROCK (NOMINEES) LTD | 940 | B ORDINARY SHARES 940 |
| CAPITAL PARTNERS LLP | 736 | B ORDINARY SHARES 736 |
| EMBARK INVESTMENT SERVICES NOMINEES LIMITED | 50 | B ORDINARY SHARES 50 |
Contact the editorial team at editorial@fundingspotter.com